Summary of RadNet Presentation at KeyBank's Healthcare Forum Company Overview - **Company**: RadNet - **Industry**: Outpatient diagnostic imaging services - **Operations**: Over 400 centers across the U.S., primarily in 10 states - **Key Features**: Complementary digital health platform, self-developed IT platform, and AI integration [1][2] 2025 Performance and 2026 Outlook - **2025 Challenges**: Faced California wildfires and severe winter weather impacting operations [5] - **2025 Growth**: Achieved unprecedented growth in MRI volume (over 11%), CT volume (mid-single digits), and PET CT (over 14%) [6] - **Acquisitions**: Completed tuck-in acquisitions, including 13 centers in Southwest Florida and 6 centers in Indiana [7] - **Digital Health Growth**: Nearly 100% growth in digital health revenue, ending the year with $92 million [7] - **2026 Guidance**: Projected revenue growth of 17%-19% for imaging centers and close to 50% for digital health [8] Business Model and Market Position - **Symbiotic Relationship**: Digital health division is an extension of the imaging center business, aimed at improving workflow and efficiency [10][11] - **Technological Advancements**: Emphasis on AI, machine learning, and new technology to transform the industry [12] Revenue and EBITDA Growth Drivers - **Revenue Growth Factors**: - Acquisitions contributing to inorganic growth - Continued same-center performance with advanced imaging driving growth [14][15] - Pricing benefits from Medicare and commercial payer mix [15] - **EBITDA Growth**: Expected to grow faster than revenue, driven by operational efficiencies and expansion of hospital joint ventures [13] Advanced Imaging Trends - **Market Shift**: Over 200 basis point shift towards advanced imaging due to technology advancements and aging population [19] - **Capacity Improvements**: Upgraded MRI scanners and AI-powered scheduling to increase patient throughput [20][21] Hospital Joint Ventures - **JV Model Benefits**: - Hospitals seek partnerships to adapt to outpatient care trends and improve operational efficiency [23][24] - RadNet benefits from hospital relationships to capture imaging referrals [27] - **Current Status**: 36% of centers in joint ventures, with potential for growth beyond 50% [28] Digital Health Division - **Growth Projections**: Guiding for 45%-55% growth in annual recurring revenue (ARR) with a target of $140 million [35] - **Key Products**: - EBCD program with 46% patient adoption - iCAD acquisition expected to enhance digital health revenue [36][37] - Growth in AI clinical solutions for lung and thyroid health [38] Gleamer Acquisition - **Strategic Fit**: Gleamer enhances RadNet's AI capabilities, with significant ARR growth and cross-selling opportunities [40][43] - **Market Position**: Combined entity positioned as the largest radiology AI company globally [44] Capital Allocation Strategy - **Opportunistic Approach**: Focus on imaging center acquisitions and joint ventures, with a disciplined approach to capital deployment [46][47] - **Financial Position**: Anticipating over $100 million in free cash flow, maintaining liquidity for future opportunities [48] Regulatory Considerations - **Site Neutrality Impact**: Potential positive implications for RadNet, as hospitals may seek partnerships to adapt to regulatory changes [50][52] This summary encapsulates the key points discussed during the RadNet presentation, highlighting the company's performance, strategic direction, and market dynamics.